nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—Gadoxetate—ABCC2—esophageal cancer	0.0277	1	CrCbGaD
Gadofosveset trisodium—Abscess—Cisplatin—esophageal cancer	0.00826	0.0085	CcSEcCtD
Gadofosveset trisodium—Ageusia—Cisplatin—esophageal cancer	0.00807	0.0083	CcSEcCtD
Gadofosveset trisodium—Infection—Carboplatin—esophageal cancer	0.0079	0.00812	CcSEcCtD
Gadofosveset trisodium—Tenderness—Cisplatin—esophageal cancer	0.00749	0.00771	CcSEcCtD
Gadofosveset trisodium—Extravasation—Cisplatin—esophageal cancer	0.00749	0.00771	CcSEcCtD
Gadofosveset trisodium—Cellulitis—Cisplatin—esophageal cancer	0.00719	0.00739	CcSEcCtD
Gadofosveset trisodium—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00714	0.00734	CcSEcCtD
Gadofosveset trisodium—Intestinal obstruction—Capecitabine—esophageal cancer	0.00707	0.00727	CcSEcCtD
Gadofosveset trisodium—Laryngeal pain—Capecitabine—esophageal cancer	0.00707	0.00727	CcSEcCtD
Gadofosveset trisodium—Ulcer—Cisplatin—esophageal cancer	0.00691	0.00711	CcSEcCtD
Gadofosveset trisodium—Pain—Carboplatin—esophageal cancer	0.0068	0.00699	CcSEcCtD
Gadofosveset trisodium—Hyperkalaemia—Cisplatin—esophageal cancer	0.00642	0.00661	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Carboplatin—esophageal cancer	0.00629	0.00646	CcSEcCtD
Gadofosveset trisodium—Fluid retention—Cisplatin—esophageal cancer	0.00621	0.00638	CcSEcCtD
Gadofosveset trisodium—Coagulopathy—Capecitabine—esophageal cancer	0.00619	0.00637	CcSEcCtD
Gadofosveset trisodium—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00599	0.00617	CcSEcCtD
Gadofosveset trisodium—Tingling sensation—Capecitabine—esophageal cancer	0.00599	0.00617	CcSEcCtD
Gadofosveset trisodium—Ageusia—Capecitabine—esophageal cancer	0.00595	0.00612	CcSEcCtD
Gadofosveset trisodium—Injection site pain—Capecitabine—esophageal cancer	0.0059	0.00607	CcSEcCtD
Gadofosveset trisodium—Rigors—Capecitabine—esophageal cancer	0.0059	0.00607	CcSEcCtD
Gadofosveset trisodium—Phlebitis—Cisplatin—esophageal cancer	0.00551	0.00566	CcSEcCtD
Gadofosveset trisodium—Chest discomfort—Capecitabine—esophageal cancer	0.00545	0.0056	CcSEcCtD
Gadofosveset trisodium—Cellulitis—Capecitabine—esophageal cancer	0.0053	0.00545	CcSEcCtD
Gadofosveset trisodium—Hypocalcaemia—Capecitabine—esophageal cancer	0.00526	0.00541	CcSEcCtD
Gadofosveset trisodium—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00523	0.00538	CcSEcCtD
Gadofosveset trisodium—Lacrimation increased—Capecitabine—esophageal cancer	0.00523	0.00538	CcSEcCtD
Gadofosveset trisodium—Burning sensation—Methotrexate—esophageal cancer	0.00516	0.00531	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Cisplatin—esophageal cancer	0.00514	0.00529	CcSEcCtD
Gadofosveset trisodium—Ulcer—Capecitabine—esophageal cancer	0.00509	0.00524	CcSEcCtD
Gadofosveset trisodium—Lung disorder—Methotrexate—esophageal cancer	0.00507	0.00521	CcSEcCtD
Gadofosveset trisodium—Cyanosis—Methotrexate—esophageal cancer	0.00507	0.00521	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0049	0.00504	CcSEcCtD
Gadofosveset trisodium—Neck pain—Capecitabine—esophageal cancer	0.00488	0.00502	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00484	0.00498	CcSEcCtD
Gadofosveset trisodium—Hyponatraemia—Cisplatin—esophageal cancer	0.00476	0.0049	CcSEcCtD
Gadofosveset trisodium—Fluid retention—Capecitabine—esophageal cancer	0.00457	0.0047	CcSEcCtD
Gadofosveset trisodium—Necrosis—Methotrexate—esophageal cancer	0.00457	0.0047	CcSEcCtD
Gadofosveset trisodium—Abscess—Methotrexate—esophageal cancer	0.00453	0.00466	CcSEcCtD
Gadofosveset trisodium—Irritability—Cisplatin—esophageal cancer	0.00453	0.00466	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Cisplatin—esophageal cancer	0.00445	0.00457	CcSEcCtD
Gadofosveset trisodium—Dehydration—Cisplatin—esophageal cancer	0.00441	0.00454	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Cisplatin—esophageal cancer	0.00432	0.00444	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Cisplatin—esophageal cancer	0.00429	0.00441	CcSEcCtD
Gadofosveset trisodium—Cramp muscle—Cisplatin—esophageal cancer	0.00427	0.00439	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Cisplatin—esophageal cancer	0.00424	0.00436	CcSEcCtD
Gadofosveset trisodium—Abnormal vision—Capecitabine—esophageal cancer	0.0042	0.00432	CcSEcCtD
Gadofosveset trisodium—Sepsis—Capecitabine—esophageal cancer	0.00418	0.0043	CcSEcCtD
Gadofosveset trisodium—Extravasation—Methotrexate—esophageal cancer	0.00411	0.00423	CcSEcCtD
Gadofosveset trisodium—Ear pain—Capecitabine—esophageal cancer	0.0041	0.00422	CcSEcCtD
Gadofosveset trisodium—Phlebitis—Capecitabine—esophageal cancer	0.00406	0.00418	CcSEcCtD
Gadofosveset trisodium—Sweating increased—Cisplatin—esophageal cancer	0.004	0.00411	CcSEcCtD
Gadofosveset trisodium—Swelling—Capecitabine—esophageal cancer	0.00396	0.00408	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Cisplatin—esophageal cancer	0.00393	0.00404	CcSEcCtD
Gadofosveset trisodium—Oliguria—Methotrexate—esophageal cancer	0.00389	0.004	CcSEcCtD
Gadofosveset trisodium—Ulcer—Methotrexate—esophageal cancer	0.00379	0.0039	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Capecitabine—esophageal cancer	0.00379	0.0039	CcSEcCtD
Gadofosveset trisodium—Atrial fibrillation—Capecitabine—esophageal cancer	0.00369	0.0038	CcSEcCtD
Gadofosveset trisodium—Renal impairment—Capecitabine—esophageal cancer	0.00368	0.00378	CcSEcCtD
Gadofosveset trisodium—Acute coronary syndrome—Cisplatin—esophageal cancer	0.0036	0.00371	CcSEcCtD
Gadofosveset trisodium—Renal failure—Cisplatin—esophageal cancer	0.00359	0.0037	CcSEcCtD
Gadofosveset trisodium—Myocardial infarction—Cisplatin—esophageal cancer	0.00358	0.00369	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00357	0.00367	CcSEcCtD
Gadofosveset trisodium—Hyponatraemia—Capecitabine—esophageal cancer	0.00351	0.00361	CcSEcCtD
Gadofosveset trisodium—Pain in extremity—Capecitabine—esophageal cancer	0.0035	0.0036	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Cisplatin—esophageal cancer	0.00334	0.00344	CcSEcCtD
Gadofosveset trisodium—Irritability—Capecitabine—esophageal cancer	0.00334	0.00343	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Capecitabine—esophageal cancer	0.00328	0.00337	CcSEcCtD
Gadofosveset trisodium—Dehydration—Capecitabine—esophageal cancer	0.00325	0.00335	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Cisplatin—esophageal cancer	0.00324	0.00333	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Cisplatin—esophageal cancer	0.00323	0.00332	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Cisplatin—esophageal cancer	0.00322	0.00331	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Capecitabine—esophageal cancer	0.00318	0.00327	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Cisplatin—esophageal cancer	0.00316	0.00325	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Capecitabine—esophageal cancer	0.00316	0.00325	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Capecitabine—esophageal cancer	0.00313	0.00322	CcSEcCtD
Gadofosveset trisodium—Sepsis—Methotrexate—esophageal cancer	0.00311	0.0032	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Cisplatin—esophageal cancer	0.00307	0.00316	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Cisplatin—esophageal cancer	0.00305	0.00313	CcSEcCtD
Gadofosveset trisodium—Flushing—Cisplatin—esophageal cancer	0.00305	0.00313	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Capecitabine—esophageal cancer	0.00304	0.00313	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Capecitabine—esophageal cancer	0.00302	0.00311	CcSEcCtD
Gadofosveset trisodium—Bronchospasm—Capecitabine—esophageal cancer	0.00297	0.00306	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Cisplatin—esophageal cancer	0.00297	0.00305	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Cisplatin—esophageal cancer	0.00296	0.00304	CcSEcCtD
Gadofosveset trisodium—Sweating increased—Capecitabine—esophageal cancer	0.00294	0.00303	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Cisplatin—esophageal cancer	0.00293	0.00302	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Capecitabine—esophageal cancer	0.00291	0.00299	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Capecitabine—esophageal cancer	0.0029	0.00298	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Cisplatin—esophageal cancer	0.00286	0.00294	CcSEcCtD
Gadofosveset trisodium—Erythema—Cisplatin—esophageal cancer	0.00286	0.00294	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Methotrexate—esophageal cancer	0.00282	0.0029	CcSEcCtD
Gadofosveset trisodium—Flatulence—Cisplatin—esophageal cancer	0.00282	0.0029	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Cisplatin—esophageal cancer	0.00275	0.00283	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Capecitabine—esophageal cancer	0.00273	0.0028	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Capecitabine—esophageal cancer	0.0027	0.00277	CcSEcCtD
Gadofosveset trisodium—Infestation—Capecitabine—esophageal cancer	0.0027	0.00277	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Cisplatin—esophageal cancer	0.00269	0.00277	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00269	0.00277	CcSEcCtD
Gadofosveset trisodium—Tremor—Cisplatin—esophageal cancer	0.00268	0.00275	CcSEcCtD
Gadofosveset trisodium—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00266	0.00273	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00266	0.00273	CcSEcCtD
Gadofosveset trisodium—Renal failure—Capecitabine—esophageal cancer	0.00265	0.00273	CcSEcCtD
Gadofosveset trisodium—Myocardial infarction—Capecitabine—esophageal cancer	0.00264	0.00272	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Capecitabine—esophageal cancer	0.00262	0.00269	CcSEcCtD
Gadofosveset trisodium—Haematuria—Capecitabine—esophageal cancer	0.00257	0.00264	CcSEcCtD
Gadofosveset trisodium—Irritability—Methotrexate—esophageal cancer	0.00249	0.00256	CcSEcCtD
Gadofosveset trisodium—Convulsion—Cisplatin—esophageal cancer	0.00248	0.00255	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Capecitabine—esophageal cancer	0.00246	0.00253	CcSEcCtD
Gadofosveset trisodium—Anxiety—Cisplatin—esophageal cancer	0.00242	0.00249	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00242	0.00248	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Capecitabine—esophageal cancer	0.00241	0.00248	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Capecitabine—esophageal cancer	0.00239	0.00246	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Capecitabine—esophageal cancer	0.00238	0.00245	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Capecitabine—esophageal cancer	0.00237	0.00244	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Methotrexate—esophageal cancer	0.00235	0.00242	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Cisplatin—esophageal cancer	0.00233	0.0024	CcSEcCtD
Gadofosveset trisodium—Oedema—Cisplatin—esophageal cancer	0.00233	0.0024	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Capecitabine—esophageal cancer	0.00233	0.0024	CcSEcCtD
Gadofosveset trisodium—Infection—Cisplatin—esophageal cancer	0.00232	0.00238	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Cisplatin—esophageal cancer	0.00229	0.00235	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Cisplatin—esophageal cancer	0.00228	0.00234	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Cisplatin—esophageal cancer	0.00227	0.00233	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Capecitabine—esophageal cancer	0.00226	0.00233	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Cisplatin—esophageal cancer	0.00225	0.00232	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Capecitabine—esophageal cancer	0.00225	0.00231	CcSEcCtD
Gadofosveset trisodium—Flushing—Capecitabine—esophageal cancer	0.00225	0.00231	CcSEcCtD
Gadofosveset trisodium—Anorexia—Cisplatin—esophageal cancer	0.00222	0.00229	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Capecitabine—esophageal cancer	0.00219	0.00225	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Capecitabine—esophageal cancer	0.00218	0.00224	CcSEcCtD
Gadofosveset trisodium—Hypotension—Cisplatin—esophageal cancer	0.00218	0.00224	CcSEcCtD
Gadofosveset trisodium—Chills—Capecitabine—esophageal cancer	0.00217	0.00223	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Capecitabine—esophageal cancer	0.00216	0.00222	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Methotrexate—esophageal cancer	0.00216	0.00222	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Capecitabine—esophageal cancer	0.00212	0.00218	CcSEcCtD
Gadofosveset trisodium—Erythema—Capecitabine—esophageal cancer	0.00211	0.00217	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Capecitabine—esophageal cancer	0.00211	0.00217	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Cisplatin—esophageal cancer	0.00209	0.00215	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Cisplatin—esophageal cancer	0.00208	0.00214	CcSEcCtD
Gadofosveset trisodium—Flatulence—Capecitabine—esophageal cancer	0.00208	0.00213	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Capecitabine—esophageal cancer	0.00206	0.00212	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Cisplatin—esophageal cancer	0.00203	0.00209	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Capecitabine—esophageal cancer	0.00203	0.00208	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00201	0.00207	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Methotrexate—esophageal cancer	0.00201	0.00206	CcSEcCtD
Gadofosveset trisodium—Infestation—Methotrexate—esophageal cancer	0.00201	0.00206	CcSEcCtD
Gadofosveset trisodium—Pain—Cisplatin—esophageal cancer	0.00199	0.00205	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Capecitabine—esophageal cancer	0.00199	0.00204	CcSEcCtD
Gadofosveset trisodium—Tremor—Capecitabine—esophageal cancer	0.00197	0.00203	CcSEcCtD
Gadofosveset trisodium—Renal failure—Methotrexate—esophageal cancer	0.00197	0.00203	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Cisplatin—esophageal cancer	0.00192	0.00198	CcSEcCtD
Gadofosveset trisodium—Haematuria—Methotrexate—esophageal cancer	0.00191	0.00197	CcSEcCtD
Gadofosveset trisodium—Vertigo—Capecitabine—esophageal cancer	0.00189	0.00195	CcSEcCtD
Gadofosveset trisodium—Syncope—Capecitabine—esophageal cancer	0.00189	0.00194	CcSEcCtD
Gadofosveset trisodium—Palpitations—Capecitabine—esophageal cancer	0.00186	0.00191	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Capecitabine—esophageal cancer	0.00185	0.0019	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Cisplatin—esophageal cancer	0.00184	0.0019	CcSEcCtD
Gadofosveset trisodium—Cough—Capecitabine—esophageal cancer	0.00184	0.00189	CcSEcCtD
Gadofosveset trisodium—Hypertension—Capecitabine—esophageal cancer	0.00182	0.00187	CcSEcCtD
Gadofosveset trisodium—Chest pain—Capecitabine—esophageal cancer	0.00179	0.00184	CcSEcCtD
Gadofosveset trisodium—Anxiety—Capecitabine—esophageal cancer	0.00179	0.00184	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00178	0.00183	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Methotrexate—esophageal cancer	0.00178	0.00183	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Methotrexate—esophageal cancer	0.00177	0.00182	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Capecitabine—esophageal cancer	0.00175	0.0018	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Methotrexate—esophageal cancer	0.00174	0.00179	CcSEcCtD
Gadofosveset trisodium—Confusional state—Capecitabine—esophageal cancer	0.00173	0.00178	CcSEcCtD
Gadofosveset trisodium—Oedema—Capecitabine—esophageal cancer	0.00172	0.00177	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Cisplatin—esophageal cancer	0.00172	0.00177	CcSEcCtD
Gadofosveset trisodium—Infection—Capecitabine—esophageal cancer	0.00171	0.00176	CcSEcCtD
Gadofosveset trisodium—Shock—Capecitabine—esophageal cancer	0.00169	0.00174	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Capecitabine—esophageal cancer	0.00169	0.00173	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Methotrexate—esophageal cancer	0.00168	0.00173	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Capecitabine—esophageal cancer	0.00168	0.00173	CcSEcCtD
Gadofosveset trisodium—Asthenia—Cisplatin—esophageal cancer	0.00167	0.00172	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Methotrexate—esophageal cancer	0.00167	0.00172	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Capecitabine—esophageal cancer	0.00167	0.00172	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Capecitabine—esophageal cancer	0.00166	0.00171	CcSEcCtD
Gadofosveset trisodium—Anorexia—Capecitabine—esophageal cancer	0.00164	0.00169	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Methotrexate—esophageal cancer	0.00163	0.00167	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Methotrexate—esophageal cancer	0.00162	0.00167	CcSEcCtD
Gadofosveset trisodium—Chills—Methotrexate—esophageal cancer	0.00162	0.00166	CcSEcCtD
Gadofosveset trisodium—Hypotension—Capecitabine—esophageal cancer	0.00161	0.00165	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Cisplatin—esophageal cancer	0.0016	0.00164	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Methotrexate—esophageal cancer	0.00158	0.00162	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Methotrexate—esophageal cancer	0.00157	0.00161	CcSEcCtD
Gadofosveset trisodium—Erythema—Methotrexate—esophageal cancer	0.00157	0.00161	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Capecitabine—esophageal cancer	0.00154	0.00159	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Methotrexate—esophageal cancer	0.00154	0.00158	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Capecitabine—esophageal cancer	0.00153	0.00158	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Capecitabine—esophageal cancer	0.00151	0.00156	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Capecitabine—esophageal cancer	0.00149	0.00154	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00148	0.00153	CcSEcCtD
Gadofosveset trisodium—Vomiting—Cisplatin—esophageal cancer	0.00148	0.00153	CcSEcCtD
Gadofosveset trisodium—Fatigue—Capecitabine—esophageal cancer	0.00148	0.00152	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Methotrexate—esophageal cancer	0.00148	0.00152	CcSEcCtD
Gadofosveset trisodium—Rash—Cisplatin—esophageal cancer	0.00147	0.00151	CcSEcCtD
Gadofosveset trisodium—Constipation—Capecitabine—esophageal cancer	0.00147	0.00151	CcSEcCtD
Gadofosveset trisodium—Pain—Capecitabine—esophageal cancer	0.00147	0.00151	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Cisplatin—esophageal cancer	0.00147	0.00151	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Capecitabine—esophageal cancer	0.00142	0.00146	CcSEcCtD
Gadofosveset trisodium—Vertigo—Methotrexate—esophageal cancer	0.00141	0.00145	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00141	0.00145	CcSEcCtD
Gadofosveset trisodium—Nausea—Cisplatin—esophageal cancer	0.00139	0.00142	CcSEcCtD
Gadofosveset trisodium—Cough—Methotrexate—esophageal cancer	0.00137	0.00141	CcSEcCtD
Gadofosveset trisodium—Urticaria—Capecitabine—esophageal cancer	0.00137	0.0014	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Capecitabine—esophageal cancer	0.00136	0.0014	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Capecitabine—esophageal cancer	0.00136	0.0014	CcSEcCtD
Gadofosveset trisodium—Convulsion—Methotrexate—esophageal cancer	0.00136	0.0014	CcSEcCtD
Gadofosveset trisodium—Chest pain—Methotrexate—esophageal cancer	0.00134	0.00137	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00133	0.00136	CcSEcCtD
Gadofosveset trisodium—Confusional state—Methotrexate—esophageal cancer	0.00129	0.00133	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Methotrexate—esophageal cancer	0.00128	0.00132	CcSEcCtD
Gadofosveset trisodium—Infection—Methotrexate—esophageal cancer	0.00127	0.00131	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Capecitabine—esophageal cancer	0.00127	0.0013	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Methotrexate—esophageal cancer	0.00126	0.00129	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Methotrexate—esophageal cancer	0.00124	0.00128	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Methotrexate—esophageal cancer	0.00124	0.00127	CcSEcCtD
Gadofosveset trisodium—Asthenia—Capecitabine—esophageal cancer	0.00123	0.00127	CcSEcCtD
Gadofosveset trisodium—Anorexia—Methotrexate—esophageal cancer	0.00122	0.00125	CcSEcCtD
Gadofosveset trisodium—Pruritus—Capecitabine—esophageal cancer	0.00122	0.00125	CcSEcCtD
Gadofosveset trisodium—Hypotension—Methotrexate—esophageal cancer	0.0012	0.00123	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Capecitabine—esophageal cancer	0.00118	0.00121	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Methotrexate—esophageal cancer	0.00115	0.00118	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Methotrexate—esophageal cancer	0.00114	0.00117	CcSEcCtD
Gadofosveset trisodium—Dizziness—Capecitabine—esophageal cancer	0.00114	0.00117	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Methotrexate—esophageal cancer	0.00113	0.00116	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Methotrexate—esophageal cancer	0.00111	0.00114	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.0011	0.00114	CcSEcCtD
Gadofosveset trisodium—Fatigue—Methotrexate—esophageal cancer	0.0011	0.00113	CcSEcCtD
Gadofosveset trisodium—Pain—Methotrexate—esophageal cancer	0.00109	0.00113	CcSEcCtD
Gadofosveset trisodium—Vomiting—Capecitabine—esophageal cancer	0.00109	0.00112	CcSEcCtD
Gadofosveset trisodium—Rash—Capecitabine—esophageal cancer	0.00108	0.00111	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Capecitabine—esophageal cancer	0.00108	0.00111	CcSEcCtD
Gadofosveset trisodium—Headache—Capecitabine—esophageal cancer	0.00108	0.00111	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Methotrexate—esophageal cancer	0.00105	0.00108	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00105	0.00108	CcSEcCtD
Gadofosveset trisodium—Nausea—Capecitabine—esophageal cancer	0.00102	0.00105	CcSEcCtD
Gadofosveset trisodium—Urticaria—Methotrexate—esophageal cancer	0.00102	0.00105	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Methotrexate—esophageal cancer	0.00101	0.00104	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Methotrexate—esophageal cancer	0.00101	0.00104	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Methotrexate—esophageal cancer	0.000943	0.00097	CcSEcCtD
Gadofosveset trisodium—Asthenia—Methotrexate—esophageal cancer	0.000918	0.000944	CcSEcCtD
Gadofosveset trisodium—Pruritus—Methotrexate—esophageal cancer	0.000905	0.000931	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Methotrexate—esophageal cancer	0.000876	0.000901	CcSEcCtD
Gadofosveset trisodium—Dizziness—Methotrexate—esophageal cancer	0.000846	0.00087	CcSEcCtD
Gadofosveset trisodium—Vomiting—Methotrexate—esophageal cancer	0.000814	0.000837	CcSEcCtD
Gadofosveset trisodium—Rash—Methotrexate—esophageal cancer	0.000807	0.00083	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Methotrexate—esophageal cancer	0.000806	0.000829	CcSEcCtD
Gadofosveset trisodium—Headache—Methotrexate—esophageal cancer	0.000802	0.000825	CcSEcCtD
Gadofosveset trisodium—Nausea—Methotrexate—esophageal cancer	0.00076	0.000782	CcSEcCtD
